Sign up to save your podcasts
Or
Share JAMA Oncology : Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-Risk Breast Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Oncology : Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-Risk Breast Cancer
Interview with Laura J. Esserman, MD, and W. Fraser Symmans, MD, authors of Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Laura J. Esserman, MD, and W. Fraser Symmans, MD, authors of Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial
More shows like JAMA Network
View all
Science Magazine Podcast
804 Listeners
JAMA Editors' Summary
129 Listeners
HBR IdeaCast
217 Listeners
NEJM This Week
314 Listeners
JAMA Author Interviews
165 Listeners
JAMA Clinical Reviews
483 Listeners
AFP: American Family Physician Podcast
681 Listeners
JAMA Pediatrics Editors' Summary
37 Listeners
Frankly Speaking About Family Medicine
256 Listeners
The Curbsiders Internal Medicine Podcast
3,330 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Psychiatry Author Interviews
24 Listeners
JAMA Surgery Author Interviews
6 Listeners
JAMA Medical News
87 Listeners
The Indicator from Planet Money
9,529 Listeners
Annals On Call Podcast
181 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Cardionerds: A Cardiology Podcast
409 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
AMA Update
93 Listeners
NEJM AI Grand Rounds
51 Listeners